Literature DB >> 11819860

Overexpression of hepatic plasminogen activator inhibitor type 1 mRNA in rabbits with fatty liver.

J G Fan1, L H Chen, Z J Xu, M D Zeng.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11819860      PMCID： PMC4695580          DOI： 10.3748/wjg.v7.i5.710

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN： 1007-9327            Impact factor:   5.742


× No keyword cloud information.
  30 in total

1.  Diurnal changes of fibrinolysis in patients with liver cirrhosis and esophageal varices.

Authors:  F Piscaglia; S Siringo; R C Hermida; C Legnani; M Valgimigli; G Donati; G Palareti; L Gramantieri; S Gaiani; A K Burroughs; L Bolondi
Journal:  Hepatology       Date:  2000-02       Impact factor: 17.425

2.  Effect of lipid on proliferation and activation of rat hepatic stellate cells (I).

Authors:  Lun-Gen Lu; Min-De Zeng; Ji-Qiang Li; Jing Hua; Jian-Gao Fan; Zhu-Ping Fan; De-Kai Qiu
Journal:  World J Gastroenterol       Date:  1998-12       Impact factor: 5.742

3.  Mechanism of retarded liver regeneration in plasminogen activator-deficient mice: impaired activation of hepatocyte growth factor after Fas-mediated massive hepatic apoptosis.

Authors:  M Shimizu; A Hara; M Okuno; H Matsuno; K Okada; S Ueshima; O Matsuo; M Niwa; K Akita; Y Yamada; N Yoshimi; T Uematsu; S Kojima; S L Friedman; H Moriwaki; H Mori
Journal:  Hepatology       Date:  2001-03       Impact factor: 17.425

Review 4.  Hypofibrinolysis and increased PAI-1 are linked to atherothrombosis via insulin resistance and obesity.

Authors:  I Juhan-Vague; M C Alessi; P E Morange
Journal:  Ann Med       Date:  2000-12       Impact factor: 4.709

5.  Bezafibrate attenuates the overexpression of plasminogen activator inhibitor-1 messenger RNA by a combination of mono-unsaturated fatty acid and insulin in hepG2 cells.

Authors:  Y Suzuki; T Urano; H Ihara; T Nakajima; N Nagai; Y Takada; T Taminato; A Takada
Journal:  Life Sci       Date:  2001-03-09       Impact factor: 5.037

6.  Augmentation of arterial endothelial cell expression of the plasminogen activator inhibitor type-1 (PAI-1) gene by proinsulin and insulin in vivo.

Authors:  T K Nordt; H Sawa; S Fujii; C Bode; B E Sobel
Journal:  J Mol Cell Cardiol       Date:  1998-08       Impact factor: 5.000

7.  Plasminogen activator inhibitor-1 expression is regulated by the angiotensin type 1 receptor in vivo.

Authors:  S Nakamura; I Nakamura; L Ma; D E Vaughan; A B Fogo
Journal:  Kidney Int       Date:  2000-07       Impact factor: 10.612

8.  Autocrine stimulatory mechanism by transforming growth factor beta in human hepatocellular carcinoma.

Authors:  K Matsuzaki; M Date; F Furukawa; Y Tahashi; M Matsushita; K Sakitani; N Yamashiki; T Seki; H Saito; M Nishizawa; J Fujisawa; K Inoue
Journal:  Cancer Res       Date:  2000-03-01       Impact factor: 12.701

9.  Plasma from patients with cirrhosis increases tissue plasminogen activator release from vascular endothelial cells in vitro.

Authors:  T Hayashi; A Kamogawa; S Ro; K Yamaguchi; Y Kobayashi; Y Takahashi; M Murayama
Journal:  Liver       Date:  1998-06

10.  The significance of colocalization of plasminogen activator inhibitor-1 and vitronectin in hepatic fibrosis.

Authors:  S Inuzuka; T Ueno; T Torimura; S Tamaki; H Sugawara; R Sakata; N Kusaba; M Sata; K Tanikawa
Journal:  Scand J Gastroenterol       Date:  1997-10       Impact factor: 2.423
View more
  4 in total

Review 1.  Mechanisms linking nonalcoholic fatty liver disease with coronary artery disease.

Authors:  W Nseir; A Shalata; A Marmor; N Assy
Journal:  Dig Dis Sci       Date:  2011-06-08       Impact factor: 3.199

2.  Effects of low-calorie diet on steatohepatitis in rats with obesity and hyperlipidemia.

Authors:  Jian-Gao Fan; Lan Zhong; Zheng-Jie Xu; Li-Yan Tia; Xiao-Dong Ding; Min-Sheng Li; Guo-Liang Wang
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

3.  Relationships of PAI-1 levels to central obesity and liver steatosis in a sample of adult male population in southern Italy.

Authors:  Antonio Barbato; Roberto Iacone; Giovanni Tarantino; Ornella Russo; Paolo Sorrentino; Sonia Avallone; Ferruccio Galletti; Eduardo Farinaro; Elisabetta Della Valle; Pasquale Strazzullo
Journal:  Intern Emerg Med       Date:  2009-04-07       Impact factor: 3.397

4.  Rosiglitazone attenuates atherosclerosis and increases high-density lipoprotein function in atherosclerotic rabbits.

Authors:  Chen Li; Yan Tu; Ting-Rong Liu; Zhi-Gang Guo; Di Xie; Jian-Kai Zhong; Yong-Zhen Fan; Wen-Yan Lai
Journal:  Int J Mol Med       Date:  2015-01-19       Impact factor: 4.101
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.